Displaying 25 - 36 of 71
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
5

Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" - EASL Congress 2024

View
Viral Hepatitis
1

GlaxoSmithKline: Nothing about me without me - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Displaying 25 - 36 of 71